amylyx.com (AMLX) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Amylyx Pharmaceuticals (AMLX) uzoq muddatli talab va patent himoyasiga tayangan holda, og'ir miya patologiyalari uchun terapiya usullari bilan shug'ullanadi. Rahbariyat hozirda asosiy inson kapitalini saqlab qolish maqsadida olimlarning ketayotgani bilan kurashmoqda. GURU.Markets platformasida 0.02 miqdorini tashkil etgan aksiya narxi tendentsiyasi, avvalgi muvaffaqiyatsizliklardan keyin dori portfelining yangilanishiga va neyrodegeneratsiyaga qarshi davolash usullarining yangi sinovlariga bog'liq.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261030&filename=GURU_Markets_-_AMLX_-_Amylyx-Pharmaceuticals_-_Long-Term-Debt-to-Equity-Ratio "AMLX - Amylyx Pharmaceuticals, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 30.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Amylyx Pharmaceuticals (AMLX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Amylyx Pharmaceuticals|AMLX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati amylyx.com|AMLX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Amylyx Pharmaceuticals, Inc.|AMLX - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli qarz Amylyx Pharmaceuticals|Tezkor likvidlik amylyx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:AMLX Amylyx Pharmaceuticals Inc
Ushbu koeffitsiyent kapital tarkibida uzoq muddatli majburiyatlarning ulushini belgilaydi, bu esa daromadlar pasaygan taqdirda moliyaviy leveraj va to'lovga qobiliyatsizlik xavfini baholash imkonini beradi. Amylyx Pharmaceuticals (AMLX) kompaniyasining uzoq muddatli qarzlarning kapitalga nisbati grafigini tahlil qilish orqali investor, mahsulotlar portfelining torligini hisobga olgan holda, kompaniyaning dori vositalarini chaqirib olish yoki sug'urta qoplama muammolari kabi potentsial xavflarga chidamliligini baholashi mumkin.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Therapeutics Inc TRVI|Praxis Medicines - Uzoq muddatli qarzning o'z kapitaliga nisbati|Anavex Life Sciences Corp (AVXL) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CBLL - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (alector.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Annexon Biosciences (ANNX)|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NGNE (Neurogene Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. NMRA|SCLX (Scilex Holding) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACOG (Alpha Cognition)|CGTX: Uzoq muddatli qarzning kapitalga nisbati|inhibikase.com (IKT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences|ASRT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|Uzoq muddatli qarzning o'z kapitaliga nisbati vistagen.com VTGN|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati acumenpharm.com ABOS|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Alterity Therapeutics (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen (PEPG)|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|Uzoq muddatli qarzning kapitalga nisbati relmada.com|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|Uzoq muddatli kreditlarning kapitalga nisbati GRCE|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|revivapharma.com (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NeurAxis Inc. (NRXS) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzning kapitalga nisbati Addex Therapeutics Ltd. ADXN|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cyclerion Therapeutics (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati